418 related articles for article (PubMed ID: 28403119)
1. Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome.
Tolppanen H; Rivas-Lasarte M; Lassus J; Sadoune M; Gayat E; Pulkki K; Arrigo M; Krastinova E; Sionis A; Parissis J; Spinar J; Januzzi J; Harjola VP; Mebazaa A;
Crit Care Med; 2017 Jul; 45(7):e666-e673. PubMed ID: 28403119
[TBL] [Abstract][Full Text] [Related]
2. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
[TBL] [Abstract][Full Text] [Related]
3. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
[TBL] [Abstract][Full Text] [Related]
4. Role of receptor for advanced glycation end products in cardiogenic shock.
Selejan SR; Pöss J; Hewera L; Kazakov A; Böhm M; Link A
Crit Care Med; 2012 May; 40(5):1513-22. PubMed ID: 22430238
[TBL] [Abstract][Full Text] [Related]
5. Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock.
Masson S; Caironi P; Fanizza C; Carrer S; Caricato A; Fassini P; Vago T; Romero M; Tognoni G; Gattinoni L; Latini R;
Crit Care Med; 2016 Apr; 44(4):707-16. PubMed ID: 26571184
[TBL] [Abstract][Full Text] [Related]
6. A Pilot Study of the Association of Amino-Terminal Pro-B-Type Natriuretic Peptide and Severity of Illness in Pediatric Septic Shock.
Melendez E; Whitney JE; Norton JS; Silverman M; Monuteaux MC; Bachur RG
Pediatr Crit Care Med; 2019 Feb; 20(2):e55-e60. PubMed ID: 30395024
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock.
Luyt CE; Landivier A; Leprince P; Bernard M; Pavie A; Chastre J; Combes A
J Crit Care; 2012 Oct; 27(5):524.e7-14. PubMed ID: 22386227
[TBL] [Abstract][Full Text] [Related]
8. Role of N-terminal pro-B-type natriuretic peptide in the prediction of outcomes in ST-elevation myocardial infarction complicated by cardiogenic shock.
Sharma YP; Kanabar K; Santosh K; Kasinadhuni G; Krishnappa D
Indian Heart J; 2020; 72(4):302-305. PubMed ID: 32861389
[TBL] [Abstract][Full Text] [Related]
9. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y
Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
[TBL] [Abstract][Full Text] [Related]
10. NTproBNP and ST2 as predictors for all-cause and cardiovascular mortality in elderly patients with symptoms suggestive for heart failure.
Boman K; Thormark Fröst F; Bergman AR; Olofsson M
Biomarkers; 2018; 23(4):373-379. PubMed ID: 29355441
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.
van Diepen S; Newby LK; Lopes RD; Stebbins A; Hasselblad V; James S; Roe MT; Ezekowitz JA; Moliterno DJ; Neumann FJ; Reist C; Mahaffey KW; Hochman JS; Hamm CW; Armstrong PW; Granger CB; Theroux P;
Int J Cardiol; 2013 Oct; 168(3):2127-33. PubMed ID: 23394896
[TBL] [Abstract][Full Text] [Related]
12. Clinical picture and risk prediction of short-term mortality in cardiogenic shock.
Harjola VP; Lassus J; Sionis A; Køber L; Tarvasmäki T; Spinar J; Parissis J; Banaszewski M; Silva-Cardoso J; Carubelli V; Di Somma S; Tolppanen H; Zeymer U; Thiele H; Nieminen MS; Mebazaa A; ;
Eur J Heart Fail; 2015 May; 17(5):501-9. PubMed ID: 25820680
[TBL] [Abstract][Full Text] [Related]
13. Serial Measurement of Amino-Terminal Pro-B-Type Natriuretic Peptide Predicts Adverse Cardiovascular Outcome in Children With Primary Myocardial Dysfunction and Acute Decompensated Heart Failure.
Medar SS; Hsu DT; Ushay HM; Lamour JM; Cohen HW; Killinger JS
Pediatr Crit Care Med; 2015 Jul; 16(6):529-34. PubMed ID: 25856472
[TBL] [Abstract][Full Text] [Related]
14. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
[TBL] [Abstract][Full Text] [Related]
15. Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement.
Lindman BR; Breyley JG; Schilling JD; Vatterott AM; Zajarias A; Maniar HS; Damiano RJ; Moon MR; Lawton JS; Gage BF; Sintek MA; Aquino A; Holley CL; Patel NM; Lawler C; Lasala JM; Novak E
Heart; 2015 Sep; 101(17):1382-8. PubMed ID: 26037104
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
Dhillon OS; Narayan HK; Quinn PA; Squire IB; Davies JE; Ng LL
Am Heart J; 2011 Jun; 161(6):1163-70. PubMed ID: 21641364
[TBL] [Abstract][Full Text] [Related]
17. Outcome of patients with cardiac amyloidosis admitted to an intensive care unit for acute heart failure.
d'Humières T; Fard D; Damy T; Roubille F; Galat A; Doan HL; Oliver L; Dubois-Randé JL; Squara P; Lim P; Ternacle J
Arch Cardiovasc Dis; 2018 Oct; 111(10):582-590. PubMed ID: 29709420
[TBL] [Abstract][Full Text] [Related]
18. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
[TBL] [Abstract][Full Text] [Related]
19. Multimarker approach with cystatin C, N-terminal pro-brain natriuretic peptide, C-reactive protein and red blood cell distribution width in risk stratification of patients with acute coronary syndromes.
Vieira C; Nabais S; Ramos V; Braga C; Gaspar A; Azevedo P; Álvares Pereira M; Salomé N; Correia A
Rev Port Cardiol; 2014 Mar; 33(3):127-36. PubMed ID: 24674467
[TBL] [Abstract][Full Text] [Related]
20. Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.
Obokata M; Sunaga H; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
Am Heart J; 2016 Sep; 179():29-41. PubMed ID: 27595677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
